Klinische Untersuchung Zur Pflege Trockener Haut Mit Physiogel AI Lotion Und Physiogel Lotion

University Hospital Muenster1 site in 1 country100 target enrollmentApril 2008

ConditionsEczema

InterventionsPhysiogel AI Lotion, Physiogel Lotion

DrugsPhysiogel AI Lotion, Physiogel Lotion

Overview

Phase: Not Applicable
Intervention: Physiogel AI Lotion, Physiogel Lotion
Conditions: Eczema
Sponsor: University Hospital Muenster
Enrollment: 100
Locations: 1
Primary Endpoint: Improvement of dry skin Improvement of burning, stinging and pruritus (if present) Improvement of quality of life
Status: Completed
Last Updated: 15 years ago

Overview Investigators Eligibility Criteria Arms & Interventions Outcomes Sites Similar Trials

Overview

Brief Summary

Dry skin is a physiological condition and is characterized in contrast to greasy skin by roughness, desquamation and lack of brightness of the skin surface. Subjectively, feelings of tension, burning and itching can occur. Dry skin needs special care due to its structural and functional characteristics.We monitor an application test the Dermatocosmetics Oilatum Physiogel AI Lotion and Physiogel Lotion. This is to be accomplished with patients having dry skin. The influence on the roughness of skin, desquamation, feeling of tingle, burning and itching should be documented. If sleep quality is disturbed by tingle or itch, this will be monitored, too.

Detailed Description

The included patients use the lotion twice daily for a two-week period. If not sufficient it can be continued up to a four-weeks period. Additionally, the patient receives a documentation sheets to note several parameters. In a sensory assessment, product specific parameter such as spreadability, permeability, lubricating, smell of lotion and cosmetic acceptance during the treatment will be assessed (at the beginning, after 2 weeks, after 4 weeks, 2 weeks after stopping treatment). After four weeks the skin care measurement will be terminated and the patient can continue with a treatment of his choice. A monitoring of at least 50 patients per preparation is intended.

Registry

clinicaltrials.gov

Start Date

April 2008

End Date

November 2009

Last Updated

15 years ago

Study Type

Interventional

Study Design

Single Group

Sex

All

Investigators

Sponsor

University Hospital Muenster

Eligibility Criteria

Inclusion Criteria

•Patients age: over 18 years
•Willing to apply skin care for 2 to 4 weeks, twice daily
•Willing to fulfill questionnaires / home diaries: self-perception of roughness of the skin, desquamation of the skin, lack of skin brightness, feelings of tension and itching

Exclusion Criteria

•Participation in any other research study during the previous 4 weeks.
•Previous participation in this study.
•Concurrent participation in any other research study involving an investigational product.
•Current need for the use of topical steroids.
•History of skin disease or allergy likely to interfere with the study or known sensitivity to the test product or its ingredients.
•Subjects considered unable or unlikely to fulfill diaries.
•Employees of (CRO) or Stiefel Laboratories, or an immediate family member (partner, offspring, parents, siblings or sibling's offspring) of an employee.
•History of cancer.
•Recent immunization (less than 10 days prior to the use of the test product).